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Background: The genome of the important industrial host Bacillus subtilis does not encode the glyoxylate shunt,
which is necessary to utilize overflow metabolites, like acetate or acetoin, as carbon source. In this study, the
operon encoding the isocitrate lyase (aceB) and malate synthase (aceA) from Bacillus licheniformis was transferred
into the chromosome of B. subtilis. The resulting strain was examined in respect to growth characteristics and
qualities as an expression host.
Results: Our results show that the modified B. subtilis strain is able to grow on the C2 compound acetate.
A combined transcript, protein and metabolite analysis indicated a functional expression of the native glyoxylate
shunt of B. lichenifomis in B. subtilis. This metabolically engineered strain revealed better growth behavior and an
improved activity of an acetoin-controlled expression system.
Conclusions: The glyoxylate shunt of B. licheniformis can be functionally transferred to B. subtilis. This novel strain
offers improved properties for industrial applications, such as growth on additional carbon sources and a greater
robustness towards excess glucose feeding.
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Glycolic acidBackground
The anaplerotic glyoxylate cycle is a variation of the
tricarboxylic acid cycle (TCA cycle), which allows acetyl-
CoA to be used to replenish carbon for anabolic pro-
cesses [1]. The isocitrate lyase of this shunt prevents a
carbon loss by cleaving isocitrate into glyoxylate and
succinate, thus avoiding the decarboxylation of iso-
citrate and 2-oxoglutarate. Glyoxylate and acetyl-CoA
are joined to malate by the malate synthase, the second
enzyme of the glyoxylate shunt, which allows for the re-
generation of oxaloacetate that is henceforth available
for anabolic activities via the TCA cycle or gluconeo-
genesis. From a bioprocessing viewpoint, this ability is
especially interesting for bacteria that previously pro-
duced overflow metabolites. In terms of Bacillus subtilis
such conditions include aerobic growth with excess* Correspondence: schweder@uni-greifswald.de
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reproduction in any medium, provided the orglucose or anaerobic nitrate respiration [2,3] and lead to
the formation of acetate as well as acetoin and 2,3-
butanediol. Industrial fermentation processes are usually
so designed that overflow metabolism is avoided or at least
limited. The overflow metabolism leads to metabolic shifts
towards less efficient pathways and causes energy spilling
reactions [3]. Nevertheless the mixing of incoming, highly
concentrated feed solutions is insufficient in industrial-
scale bioreactors and always gives rise to zones of excess
carbon source [4]. For Escherichia coli it has been shown
that the formation of overflow metabolites, especially acet-
ate, hampers large scale fed-batch processes. Accumulated
acetate has been observed to have adverse effects on target
product formation and cell growth [5].
After depletion of the preferred carbon source (e.g. glu-
cose), the excreted overflow metabolites are converted
into metabolically utilizable acetyl-CoA [6]. Since B.
subtilis lacks the capability to conduct the glyoxylate cycle,
it can only make use of the energy provided by the over-
flow metabolites in the form of reduction equivalents,
which are generated during the TCA cycle. In this studyl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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relative Bacillus licheniformis [7] was investigated in B.
subtilis. It is shown that the functional expression of this
operon enables B. subtilis to utilize the overflow metabolite
acetate as a carbon source and resulted in a more robust
growth behavior with excess glucose and an increased pro-
duction of a recombinant reporter enzyme.
Results
Primer extension experiments with B. licheniformis showed
that the transcript of the glyoxylate operon (aceBA) starts
231 bp upstream of the aceB gene with a potential pro-
moter sequence at the position of 4,040,629 to 4,040,601 in
the genome (personal communication A. Ehrenreich). Ana-
lysis of the 3’-end with the Vienna RNA package [8] re-
vealed a potential terminator structure (4,037,415 to
4,037,434; –ΔG= 15.2) and typical Shine-Dalgarno se-
quences (SDS) in front of a hypothetical protein sequence
(RBS1: 4,040,515 to 4,038,510), aceB (RBS2: 4,040,338 to
4,040,332) and aceA (RBS3: 4,038,731 to 4,038,726)
(Figure 1A). These SDS meet the requirements for an effi-
cient ribosomal binding side of B. subtilis [9].
First attempts to construct plasmids containing the
complete glyoxylate operon of B. licheniformis failed with
E. coli as subcloning host. Transformation of the ligation
reaction using E. coli as a shuttle host resulted in plasmids
containing different fragments of the genes, but never the
complete operon, making it likely that ORFs of the
glyoxylate operon are expressed in E. coli and interfereFigure 1 Structure of the aceBA-operon of B. licheniformis (A) and sch
(B). (A) The aceBA-operon of B. licheniformis DSM13 encodes the malate synt
essential for the functional transfer of this operon in B. subtilis. (RBS: ribosome
promoter but a neomycin resistance cassette (NeoR) were integrated into the
second step the resulting strain was transformed with a DNA-fragment conta
the aceBA-operon by selecting on the erythromycin resistance cassette (EryR).with its metabolism. Therefore, we constructed the plas-
mids in such a manner that one plasmid contained only
the aceB and the aceA genes without a promoter and an-
other plasmid contained the native aceBA-operon specific
promoter and the above mentioned hypothetical protein
(Figure 1B). Both plasmids could be propagated in E. coli
and the transformation of B. subtilis in a two-step-proced-
ure worked well, yielding B. subtilis ACE which contains
the native glyoxylate operon of B. licheniformis in its
chromosomal amyE locus.
In mineral salt medium containing a mixture of glycerol,
acetate and acetoin as carbon sources, the glyoxylate-
positive strain B. subtilis ACE reached a significantly higher
final maximal optical density than the wild type strain
(Figure 2). Glycerol is in this medium the preferred carbon
and energy source for B. subtilis. In contrast to the wild
type (WT) B. subtilis ACE showed a diauxic growth pat-
tern with a slightly reduced specific growth rate during the
mid-exponential growth phase, indicating a utilization of
acetate but also acetoin for its growth.
A quantitative aceB-mRNA-analysis indicated a basal
expression of the aceBA-operon in B. subtilis ACE during
the exponential growth on glycerol (Figure 3). A signifi-
cant induction (~7-fold) occurred during the diauxic tran-
sition phase. The B. subtilis control strain (WT) did not
show a detectable aceB-mRNA signal in any of the experi-
ments (data not shown). The expression of the isocitrate
lyase (AceA) in the aceBA positive strain was detectable in
the cytoplasmic soluble proteome during the transient andematic representation of its transfer into the B. subtilis genome
hase (aceB), the isocitrate lyase (aceA) and a hypothetical protein which is
binding site). (B) In a first step, the aceB and aceA genes without a
chromosomal amyE-locus of B. subtilis by a double cross-over event. In a
ining the gene of the hypothetical protein and the native promoter of
Figure 2 Growth comparison of the B. subtilis WT and the glyoxylate shunt - expressing ACE strain. The cultivations were performed in
three biological replicates in mineral salt medium (MSM) containing 0.08% glycerol, 0.2% acetoin and 0.5% acetate. t1-t5 indicate sampling points.
Figure 3 aceB-mRNA quantification by real-time-RT-PCR. The
length of the detected aceB-transcript was 300 nucleotides. ACE = B.
subtilis encoding the aceBA-operon. t1-t4 sampling points
throughout the growth curve as shown in Figure 2. N = 3, therefore
the box plot does not show quartils.
Kabisch et al. Microbial Cell Factories 2013, 12:72 Page 3 of 10
http://www.microbialcellfactories.com/content/12/1/72stationary phase by mass spectrometry analyses. No
AceA-specific peptides could be identified in the negative
control (WT). However, no peptides could be detected for
the malate synthase (AceB) and the hypothetical protein
in any of the samples. The difficulty of the identification of
AceB-specific peptides was not unexpected, since the pro-
tein has so far eluded identification in several gel-based
studies of B. licheniformis (personal communication B.
Voigt, [10]). With a molecular weight of about 5 kDa, the
absence of peptides for the hypothetical protein can be
explained by the difficulties of analyzing such small pro-
teins with the gel-based MALDI-TOF mass spectrometry.
The analysis of extracellular metabolites revealed the
consumption of glycerol as the preferred carbon source
and a nearly constant level of acetoin and acetate during
this first growth phase (Figure 4). Thus, in contrast to
growth on glucose [6,11], B. subtilis does not produce
overflow metabolites like acetate or acetoin in detectable
amounts while using glycerol as main carbon source. Both
strains showed a weak utilization of acetate and acetoin
already during the late exponential growth phase on gly-
cerol. However, the glyoxylate cyle - positive ACE strain
revealed a significant higher utilization of acetate but also
of acetoin compared to the WT. After exhaustion of gly-
cerol the ACE strain started to accumulate glycolic acid.
In contrast, no such accumulation could be detected in
the B. subtilis WT strain. It is interesting to note that the
final glycolic acid concentration in the B. subtilis ACE mu-
tant strain was almost three times as high as that of the
aceBA-donor strain B. licheniformis DSM13 (data not
shown). Glyoxylate could not be detected in the super-
natant of any strain. 2.3-butanediol accumulated in both
B. subtilis strains and was not consumed (Figure 4).
Figure 4 Quantification of selected extracellular metabolites. 1H-NMR-quantified metabolites of the added carbon sources and selected
byproducts of the B. subtilis wild type (WT) and the B. subtilis ACE strain with the glyoxylate cycle operon (ACE). The corresponding sampling
points are indicated in Figure 2.
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‘EnBase Flo’ revealed a clear distinction of growth pat-
terns between the WT and the glyxolate cycle - positive
mutant (Figure 5). B. subtilis ACE reached higher cell
densities and was not negatively affected by the addition
of excess glucose. In contrast, the WT only exhibited a
relative stable growth behavior without additional glu-
cose. The excess of glucose led to a lysis of the WT cells
after 360 min of incubation. All cultures, except the WT
cultures with 0.2 or 0.4% glucose, featured a pronounced
biofilm formation in the late growth phase (at about
1200 min). Additionally, B. subtilis ACE produced a red
pigment, which was not detectable in the WT cultures.
The formation of biofilms and pigments hampered the
exact determination of the optical density in these exper-
iments. However, the determined trend in the growth
behavior was reproducible for all investigated biological
replicates. The absorption maximum of the observed red
pigment in these cultures was at 410 nm, while only a
minor absorption could be observed at 500 nm [12].Care was as well taken not to pipette the biofilm but only
the cells underneath. It should be noted that due to differ-
ent path lengths and measurement methods of the plate
reader in comparison to a standard photometer, OD
values shown in Figure 5 are relative values. The final ODs
of the cultures measured with a standard 1 cm path length
photometer are given in the legend of Figure 5.
In order to further characterize the glyoxylate shunt - ex-
pressing B. subtilis strain, studies using an acetoin-
inducible promoter (acoA) and a secreted alpha-amylase
[13] as a reporter enzyme were carried out. In order to in-
crease the transcription activity of the acoA-promoter
the MSM growth medium was supplemented with 0.5%
acetoin. Similar to the growth experiments shown in
Figure 2 the ACE-strain revealed a higher final optical
density in comparison to the WT (Figure 6). It is interest-
ing to note that the B. subtilis ACE strain enables an in-
creased acoA-directed amylase overproduction under these
conditions. These experiments also indicate that the acoA-
promoter is repressed during growth on glycerol [14] and
Figure 5 Simulated of fed-batch and high glucose conditions with EnBase Flo. Wild type = B. subtilis ΔamyE; B. subtilis ACE = glyoxylate
cycle - positive mutant with the aceBA-operon integrated into the amyE-locus. The final optical densities (OD) were measured with a 1 cm path
length cuvette with the following results: WT 0% glucose = 8.77; WT 0.2% glucose = 2.05; WT 0.4% glucose = 1.85; ACE 0% glucose = 15.18; ACE
0.2% glucose = 16.16; ACE 0.4% glucose = 16.84.
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and during growth on acetate in the B. subtilis ACE strain
after glycerol has been consumed.
Discussion
Relatively little is known about the regulation of the
glyoxylate cycle in Gram-positive bacteria. Results of
this study indicate a control of the aceBA-operon ofFigure 6 Influence of the glyoxylate shunt on the acoA-controlled am
both strains the native alpha-amylase gene was disrupted and a functional cop
Exact sampling points for activity measurements are indicated in small type. MeB. licheniformis in B. subtilis at the transcriptional level.
A transcriptional regulation of the glyoxylate shunt
has also been shown for the Gram-positive bacterium
Corynebacterium glutamicum, where the expression of
the malate synthase and isocitrate lyase is positively
controlled by the LuxR-type transcriptional regulator
RamA in the presence of acetate [15]. Voigt et al.
detected a strong induction of the AceB expression inylase overproduction of B. subtilis ACE compared to the WT. In
y under control of the acoA-promoter was integrated into the sacA-locus.
dium: MSM+ 0.5% acetate, 0.08% glycerol, 0.5% acetoin.
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level as soon as the preferred carbon and energy source
glucose is exhausted [16]. Schroeter et al. [10] could de-
termine an induction of the glyoxylate shunt during
peroxide stress experiments, which was attributed to an
irreversible oxidation of the isocitrate dehydrogenase
(ICDH). However, it is also shown in our study that the
region encoding the hypothetical protein (BL02643) in
front of aceBA is essential for a functional transfer of
the glyoxylate shunt to B. subtilis. Strain constructs
missing this putative regulatory region of the operon fail
to grow on acetate (data not shown). It can be con-
cluded that this small protein plays an essential role in
the regulation of the glyoxylate cycle activity.
The incorporation of the glyoxylate shunt - encoding
operon led to growth of B. subtilis ACE on the overflow
metabolite acetate and to a lesser degree on acetoin. A
diauxic growth with a preferred utilization of glycerol
over acetate can be derived from the metabolite analyses
(Figure 4). However, the current version of the glyoxylate
cycle - positive strain B. subtilis ACE failed to reach the
same maximal optical density as B. licheniformis (data not
shown). A possible reason for its earlier growth arrest
might be the accumulation of glycolic acid (see Figure 4).
This small alpha-hydroxy acid has been described as a po-
tent inhibitor of the isocitrate lyase of Pseudomonas
indigofera [17] and could disable B. subtilis ACE to con-
tinue utilizing acetate as a replenishing carbon source
through its glyoxylate cycle. Glycolic acid is also formed in
B. licheniformis, but to a much smaller extent (data not
shown). B. licheniformis DSM13 possesses a putative
glyoxylate reductase (ORF BL02138) which exhibits a 70%
identity to a similar enzyme (gyaR) of Bacillus pumilus
ATCC 7061. This putative glyoxylate reductase (ORF
BL02138) could catalyze the reduction of glyoxylate to gly-
colic acid and could thus lead to a reduced accumulation
of glycolic acid in B. licheniformis.
The accumulation of 2.3-butanediol in B. subtilis dur-
ing the exponential and stationary phase is likely due to
the activity of the acetoin reductase/2.3-butanediol de-
hydrogenase (bdhA) [18]. The remaining acetoin could
block the reverse reaction that would transform the 2.3-
butanediol back to acetoin. It has been reported that
the presence of acetic acid leads to an increased produc-
tion of 2.3-butanediol by B. subtilis [19]. In contrast,
B. licheniformis is able to utilize acetoin but also 2.3-
butanediol entirely (data not shown), which might
also have contributed to an increase of biomass. This is
most probably also supported by the butanediol/acetoin
reductase encoded by the budC (BL01177) gene of B.
licheniformis, which catalyzes the irreversible reduction
of 2.3-butanediol to acetoin [20]. Interestingly, the sub-
species B. subtilis subsp. spizizenii, which is of a different
lineage than the used B. subtilis strain 6051HGW [21],encodes the same potential for the 2.3-butanediol
utilization as B. licheniformis, highlighting both as po-
tential donors of the butanediol/acetoin reductase for a
further optimization of B. subtilis ACE.
The simulated EnBase fed-batch cultivation indicated an
advantage of the glyoxylate shunt - active strain B. subtilis
ACE in comparison to the WT under high glucose con-
centration conditions. Induction of a significant overflow
metabolism by addition of excess glucose presumably
resulted in the growth arrest of the WT, while the activity
of the glyoxylate shunt enabled B. subtilis ACE to exploit
too high levels of these metabolites and to reach thus ele-
vated cell densities.
This study indicates that the previously described acoA-
expression system [13] displays an improved performance
in the glyoxylate cycle - positive strain B. subtilis ACE. The
promoter of the acoABCL-operon is repressed by PTS–
sugars [22], but as demonstrated in this study also by the
non-PTS carbon source glycerol. The cheap C-source
glycerol in combination with acetate therefore offers an in-
teresting alternative for the control of the acoA-based
B. subtilis expression system. Another possible application
of B. subtilis ACE may be an auto-inducing system that de-
pends on phosphate limitation. As described by Dauner et
al. [3], B. subtilis produces large quantities of acetate dur-
ing chemostat experiments with high glucose and low
phosphate levels. The ability of B. subtilis ACE to produce
higher recombinant target protein levels, while growing on
acetate, would therefore be a suitable alternative possibility
for the application of the acoA-expression system.
Conclusion
The aceBA operon of B. licheniformis is a self-contained
metabolic entity that can be functionally transferred to
B. subtilis. The obtained strain is able to grow on acetate
as carbon source which results in an increased biomass
formation and an improved production of a recombinant
model protein. In addition, the glyoxylate cycle-positive
B. subtilis mutant cells feature greater robustness towards
excess glucose cultivations.
Methods
Construction of plasmids, strains, and genome analysis
Chromosomal DNA of Bacillus licheniformis MW3, which
is a mutant of B. licheniformis DSM13 [23], was used as
template for the amplification of the aceBA-operon. Se-
quence information was derived from the published gen-
ome of B. licheniformis DSM13 [GenBank:NC_006322].
PCRs were performed with the Phusion polymerase. The
utilized oligonucleotides are summarized in Table 1, while
the constructed plasmids and used strains are listed in
Table 2.
The plasmid pACEBA was constructed by amplifying
the aceBA-operon without its predicted promoter region
Table 1 Oligonucleotide primers used in this study
Name Sequence 5’→ 3’ Usage
aceBAfor GATCGTCTAGAGTCTCCCTACCCCTTTACAT Forward primer for aceBA operon
aceBArev GATCGGATCCAAGACAACCGGCCGGCCAAA Reverse primer for aceBA operon
Prom1-for GAAAATGGCTAAAATTGGTTATGCACGACTCTACGAAT Forward primer for integration of native promoter
Prom1-rev CGCAACGCGGGGAGGCAGACAAGGTATAGGGCGGGG
ACCAAAATCGAACAGGCTTGC
Reverse primer for integration of native promoter
SLIC-Ery-for TTATGCACGACTCTAGCCTGCAGGTCGACTGATAAGACGGTTCGTGTTCG Forward primer for EryR cassette
SLIC-Ery-rev TAATTAGACCGGTACCCGGGGATCCTCTAGCTCTTTAGCTCCTTGGAAGC Forward primer for EryR cassette
aceB-for CTGCCGCCGATCAGCACATGC Forward primer for mRNA-standard of aceB
aceB-rev CCCGCAAATTAACCTGGC Reverse primer for mRNA-standard of aceB
aceB-rev-T7 TAATACGACTCACTATAGGGCCCGCAAATTAACCTGGC Reverse primer for mRNA-standard of aceB with T7-promoter
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pBGAB [26] plasmid were cut with XbaI and BamHI and
ligated using T4-ligase. To integrate the native promoter
and the hypothetical protein in front of the aceBA-operon,
the pBGAG plasmid was cut with SmaI and NotI and an
erythromycin cassette from pMTL500 [27] was inserted
yielding the plasmid pAMYSSE. Hereafter, this plasmid
was cut with NarI and EcoRI and the PCR product
resulting from the Prom1-primer pair was integrated via
a modified sequence and ligation-independent cloning
method [24]. Electroporation of the plasmids into E. coli
was performed as previously described [28]. All utilized
enzymes were purchased from New England BiolabsTable 2 Strains and plasmids used in this study
Strain Genotype
B. subtilis 6051HGW Wild type
B. licheniformis MW3 ΔhsdR1, ΔhsdR2
B. subtilis ACE ΔamyE::aceBA
B. subtilis ACEProm1 ΔamyE::aceBA
B. subtilis ΔamyE ΔamyE::EryR
B. subtilis acoAamyE ΔamyE::EryR ΔsacA::acoAamyESSS
B. subtilis ACEamyE ΔamyE::aceBAProm1SSE ΔsacA::acoAamyESSS
E. coli DH10B F-mcrA,(mrr-hsdRMS-mcrBC)’80lacZ,M15, lacX74, recA1 a
Plasmid Function
pBGAB Integration of genes into the amyE locus with NeoR
pACEBA aceBA chromosomal integration into the amyE locus
pMTL500 Source of ermB gene for erythromycin resistance
pAMYSSE Integration of genes into the amyE locus with EryR
pProm1 Integrating of the native aceBA promoter and the gene
pJK168 Integration of genes into the sacA-locus
pMJS2 Source of the PacoA-amyE construct
pSacAmyE Integration of the amyE gene under PacoA control into
EryR: Erythromycin resistance cassette, NeoR: Neomycin resistance cassette, amyE: Al
Phospho-sucrase gene.(Frankfurt a. M., Germany), oligonucleotides were synthe-
sized by Life Technologies (Darmstadt, Germany).
To obtain an aceBA-encoding strain, B. subtilis 60-
51HGW was transformed via natural competence [29]
using the linearized plasmid pACEBA. The clones were
selected on neomycin and the positive mutants were des-
ignated as B. subtilis ACE-P. To functionalize the operon,
pProm1 was transformed in the same manner into
B. subtilis ACE-P with erythromycin selection resulting in
B. subtilis ACE. To examine the expression of a reporter
enzyme, B. subtilis ACE and B. subtilis 6051HGW were
transformed with pSacAmyE yielding a wild type (B. subtilis








raD139, (ara leu) 7697 [25]
Reference
[26]
without promoter This study
[27]
This study
encoding the hypothetical protein This study
J. Kumpfmüller (unpublished results)
[13]
the sacA-locus This study
pha-amylase gene, PacoA: Promoter of the acoABCL-operon, sacA:
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amylase under control of the acoA-promoter [13]. pSa-
cAmyE was constructed by cutting pJK168 and pMJS2 [13]
with XbaI and ligating the acoA-amyE fragment from
pMJS2 into the sacA landing pads of pJK168. To ensure
comparable alpha-amylase measurements, the native alpha-
amylase of B. subtilis was disrupted by the integration of
the aceBA-operon (B. subtilis ACEamyE) and an erythro-
mycin cassette of plasmid pAMYSSE (B. subtilis WTamyE)
into the amyE-locus. All plasmid constructs and chromo-
somal integrations were verified by sequencing.
The publicly available genome sequence of B. li-
cheniformis was annotated in 2004 [7]. Since then, a large
amount of novel sequences and annotations have been
published, which implicates the necessity to update previ-
ous functional assignments for organisms of interest.
Accordingly, we reannotated the genome sequence of
B. licheniformis DSM13 in the same manner as described
for B. subtilis 6051HGW [24]. In short, the GenBank file
of B. licheniformis DSM13 [GenBank:AE017333] was
imported into the GenDB 2.2 [30] pipeline and the
resulting database was used to analyze the ORFs with
JCoast [31].
Cultivation conditions
Cultivations were carried out at 37°C and 250 rpm shaking
in Erlenmeyer flasks with a maximum culture volume of
one fifth of the flasks volume. Pre-cultures were inocu-
lated from a cryo-stock and grown in LB medium for 5 h
and then transferred into the appropriate medium for
overnight cultures. Main cultures were inoculated from
exponentially growing overnight cultures. The compos-
ition of the mineral salt medium (MSM) and its trace elem-
ent solution has been described previously [24]. The MSM
was supplemented with 0.08% glycerol, 0.5% acetate, 0.2%
acetoin, and 2 mMMgSO4 if not indicated otherwise.
In order to test fed-batch like conditions, we cultivated
the glyoxylate cycle - positive mutant and the WT strain
with 3 ml EnBase Flo Liquid (# EBLM500, BioSilta Oy,
Oulu, Finland) medium in 24-deep-well plates. The EnBase
system is based on the slow release of glucose from a poly-
mer through the action of an enzyme, thus acting like
a substrate feeding pump [32]. The native amylase of
B. subtilis (amyE) has been reported to interfere with this
method (personal communication P. Neubauer). There-
fore, B. subtilis amylase knock-out strains (Table 2) were
used in all EnBase cultivations. Beside the control culture
without external glucose addition, cultures supplemented
with 0.2% and 0.4% glucose were investigated to simulate
high glucose conditions and to stimulate acetate formation.
1.5 U of the EnBase-specific hydrolase (BioSilta Oy, Oulu,
Finland) was used in all experiments. Plates were shaken at
300 rpm with an amplitude of 25 mm. Sample volume was
10 μl, with which the OD at 500 nm was determined in a1:10 dilution in a Tecan infinite M200 plate reader
(Männerdorf, CH).
RNA analysis
RNA samples were taken and prepared as previously de-
scribed [33]. An additional treatment with RNAse-free
DNAse (#79254, Qiagen, Hilden, Germany) was performed
followed by a purification with the RNA Clean-Up and
Concentration Kit (#23600) from Norgen Biotek (Thorold,
Canada).
The aceB-mRNA-standard was created with the primers
aceB-for and aceB-rev-T7 (Table 1) using the DIG RNA
Labeling Kit (SP6/T7) from Roche (Mannheim, Germany)
and substituting the DIG-labeled nucleotides with un-
labeled NTPs (Fermentas UAB, Vilnius, Lithuania).
The real-time RT-PCR analysis was performed as de-
scribed by Hoi et al. [34]. The RNA samples were pre-
pared as recommended by the supplier of the LightCyclerW
RNA Master SYBR Green I (#03064760001, Roche). The
RT-PCR reaction was prepared with the primers aceB-for
and aceB-rev (Table 1) and analyzed applying the Roche
LightCycler as suggested by the manufacturer with an
annealing temperature of 56°C.Protein analysis
The supernatant required for the alpha-amylase reporter
enzyme assay was obtained by centrifugation of 2 ml
culture at 10000 x g for 5 min at 4°C. The resulting
supernatant was transferred to a new tube and stored
at −20°C until further processing. The amylase activity
was determined by use of the Ceralpha Assay
(Megazymes, Wicklow, Ireland). To stay within the lin-
ear range, 1:200 dilutions in the suggested buffer were
prepared. Measurements were done with a Tecan infinite
M200 plate reader.
For the cytosolic proteome analysis, 8 ml of cells were
harvested by centrifugation and washed twice with TE-
buffer (10 mM Tris-Cl, pH 7.5, 1 mM EDTA) and finally
resuspended in 1 ml TE with 2 mM PMSF (Carl Roth,
Karlsruhe, Germany). Samples were transferred to cry-
otubes (Sarstedt, Nümbrecht, Germany) filled with 0.25 ml
glass beads (Sartorius AG, Göttingen, Germany) and the
cells were disrupted by bead-beating for 30 seconds at
6.5 m/s. After cooling for 5 min on ice, this procedure was
repeated twice. Cell debris was removed by 30 min centri-
fugation at 17000 x g. The supernatant was stored at −20°C.
5 μg of protein mixture were separated by SDS-PAGE [35]
and stained with silver-blue Coomassie [36].
The bands were excised using a sterile scalpel and trans-
ferred into 96 well micro titer plates (Greiner bio one,
Frickenhausen, Germany). The tryptic digest with subse-
quent spotting on a MALDI-target was carried out auto-
matically with the Ettan Spot Handling Workstation
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were washed twice with 100 μl of a solution of 50%
CH3OH and 0% 50 mM NH4HCO3 for 30 min and once
with 100 μl 75% CH3CN for 10 min. After drying at 37°C
for 17 min 10 μl trypsin solution containing 4 μg/ml tryp-
sin (Promega, Madison, WI, USA) was added and incu-
bated at 37°C for 120 min. For extraction gel pieces were
covered with 60 μl 0.1% TFA in 50% CH3CN and incu-
bated for 30 min at 40°C. The peptide-containing super-
natant was transferred into a new microtiter plate and the
extraction was repeated with 40 μl of the same solution.
The supernatants were completely dried at 40°C for
220 min. The dry residue was resuspended in 0.9 μl α-
cyano-4-hydroxy-cinnamic acid matrix (3.3 mg/ml in
50%/49.5%/0.5% (v/v/v) CH3CN/H2O/TFA) and 0.7 μl
of this solution was deposited on the MALDI target
plate. The samples were allowed to dry on the target 10
to 15 min before measurement by MALDI-TOF mass
spectrometry.
The MALDI-TOF measurement was carried out on the
AB SCIEX TOF/TOF™ 5800 Analyzer (ABSciex /MDS
Analytical Technologies, Darmstadt, Germany). This in-
strument is designed for high throughput measurement,
being automatically able to measure the samples, calibrate
the spectra and analyze the data using the TOF/TOF™
Series Explorer™ SoftwareV4.1.0. The spectra were re-
corded in a mass range from 900 to 3700 Da with a focus
mass of 1700 Da. For one main spectrum 25 sub-spectra
with 100 shots per sub-spectrum were accumulated using
a random search pattern. If the autolytical fragment of
trypsin with the mono-isotopic (M+H) +m/z at 2211.104
reached a signal to noise ratio (S/N) of at least 40, an in-
ternal calibration was automatically performed as one-
point-calibration using this peak. The standard mass devi-
ation was less than 0.15 Da. If the automatic mode failed
(in less than 1%), the calibration was carried out manually.
The five most intense peaks from the TOF-spectra were
selected for MS/MS analysis. For one main spectrum 20
sub-spectra with 125 shots per sub-spectrum were accu-
mulated using a random search pattern. The internal cali-
bration was automatically performed as one-point
-calibration with the mono-isotopic arginine (M+H) +m/
z at 175,119 or Lysine (M+H) +m/z at 147,107 reached a
signal to noise ratio (S/N) of at least 5. The peak lists were
created by using GPS Explorer™ Software Version 3.6
(build 332) with the following settings for TOF-MS: mass
range, 900–3700 Da; peak density, 20 peaks per 200 Da;
minimum S/N ratio of 15 and maximal 65 peaks per spot.
The TOF-TOF-MS settings were a mass range from 60 to
Precursor - 20 Da; a peak density of 50 peaks per 200 Da
and maximal 65 peaks per precursor. The peak list was
created for an S/N ratio of 10. All peak lists were
analysed using Mascot search engine version 2.4.0
(Matrix Science Ltd, London, UK) with a specific usersequence database and specific B. subtilis and
B. licheniformis databases.
1H-NMR for extracellular metabolite analysis
2 ml cell culture was rapidly sterile filtered into a 2 ml
tube and stored at −20°C. 400 μl of the extracellular sam-
ple was buffered to pH 7.0 by addition of 200 μl of a so-
dium hydrogen phosphate buffer (0.2 mM [pH 7.0],
including 1 mM TSP)) made up with 50% D2O to provide
a nuclear magnetic resonance (NMR)-lock signal. The
samples were measured using 1H-NMR (600.27 MHz) at
a nominal temperature of 310 K (Bruker AVANCE-II 600
NMR spectrometer, Bruker Biospin GmbH, Rheinstetten,
Germany) as described previously [37]. AMIX 3.9 was
used for data processing and analysis.
Software
Graphs were created using R [38] and, where applicable,
with the ggplot2 package [39]. Graphs for metabolites were
created with VANTED V2.1.3 [40]. Genome analysis was
done with Geneious version 5.6.2 created by Biomatters
(Auckland, NZ) available from www.geneious.com. Free
Gibbs-Energy (−ΔG) of mRNA structures was determined
with UNAfold [41].
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